The examination of antimicrobial structure-activity relationships of 93 volatile phenylpropanes (VPs) and 21 related aromatic compounds revealed a dependence of antimicrobial activity from the kind and number of substituents on the aromatic ring, their substitution pattern and microbial characteristics, such as Gram coloring and strain specific factors. Eugenol isomers were predominantly inhibitory in a concentration range from 25 to 2000 mg/L against all microorganisms tested, which were three strains of Escherichia coli and Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, Bacillus subtilis, Listeria monocytogenes, and Candida albicans. Etherified VPs were either less active or inactive depending on the type of side chain and/or substitution pattern. Differences in the antimicrobial activity of cis-and trans-isomers were observed. Species specific structure-activity relationships exist as was demonstrated with the Gram-negative bacteria (inactivity of E-ortho-eugenol) C. albicans (activity of di-and threefold methoxylated 1-propenylbenzenes), S. aureus and B. subtilis (activity of di-ortho methoxylated phenolic allylbenzenes and hydroquinone derivatives). With regard to the variety of observed specific effects and natural variation of susceptibility towards VPs according to literature reference data, the chances for successful prediction by computational analysis (QSAR) appear to be limited.
VPs occur predominantly in the essential oils produced by plants of the families Apiaceae, Aristolochiaceae, Lauraceae and Lamiaceae and they are present in many food and healing plants, such as basil (Ocimum basilicum), pimento (Pimenta racemosa), allspice (Pimenta dioica), betel (Piper betle), tulsi (Ocimum sanctum), clove (Syzygium aromaticum), cassia (Cinnamomum cassia), nutmeg (Myristica fragrans), star anise (Illicium verum), fennel (Foeniculum vulgare), anise (Pimpinella anisum), parsley (Petroselinum crispum), tarragon (Artemisia dracunculus), banana (Musa sapientum), sweet flag (Acorus calamus), sassafras (Sassafras albidum), parsnip (Pastinaca sativa), and dill (Anethum graveolens) [2] .
A variety of pharmacological activities of VPs on the central nervous (antianxiety -sedative, antipsychotic, antidepressant, psycho-stimulant, psychotomimetic, analgesic and anticonvulsive) and autonomic nervous (cardiovascular, antispasmodic, antiulcer and antihistaminic) systems have been reported in the literature. In addition, some VPs causes cancer in animal feeding experiments, possess in vitro cytotoxic activity towards human cell lines, and are considered to be genotoxic.
Due to the use of eugenol (23), the main component of clove oil, in dental cement filling materials, because of its antimicrobial activity, local anesthetic and antiinflammatory properties, this compound became one of the best known VPs. Clove oil itself has a long history and was used in dentistry back in the 16 th century [3] .
The antimicrobial activity of individual VPs has been studied unsystematically to date. The commercial available compounds eugenol, trans-isoeugenol (25), estragol (13) , trans-anethol (15) , and safrol (32) have been studied frequently, whereas for the remaining VPs only scattered information can be found in the literature [4] . Abbreviations: ab = allylbenzene, pb = propenylbenzene, A = allyl, C = cis-or Z-1-propenyl, T = trans-or E-1-propenyl, com = commercial available, syn = synthesized compound, rep = reported in literature, iso = isolated compound
To determine relationships between structure and antimicrobial activity data for 93 VPs were studied with respect to their inhibitory activity towards microorganisms according to the type of side chain and substitution pattern of oxygenated substituents on the aromatic ring. Of the VPs, 77 have been chemically synthesized, 2 were isolated from essential oils, 2 were of commercial origin, and literature data were used for 14. Special attention was given to positional and side chain isomers of eugenol (19-27, 40-42, 54-58) .
In addition, 21 related aromatic compounds without a propenyl side-chain were either synthesized or were
Pauli & Kubeczka 2000  1750  2500  2500  2500  1500  2000  1750  3500  1250  2000  1750  1750  2500  3500  2000  3500  2  NT  175  300  300  500  450  450  1000  1000  600  700  550  550  900  900  450  450  3  NT  350  450  NT  NT  NT  1000  3000  225  850  NT  NT  4  NT  350  350  450  450  350  450  900  1000  350  800  <200  450  <200  300  70  275  5  NT  450  450  175  200  300  350  <200  350  300  800  300  350  700  900  250 The antimicrobial activity of phenol (1) towards all species tested was increased by introduction of a propenyl side chain (2) (3) (4) (5) (6) (7) . The position of the side chain was without significant influence on the intensity of growth inhibition. Etherification of the phenolic hydroxy group caused a loss of activity with one exception: cis-anethol (14) was found to be inhibitory towards E. coli 1 and S. aureus, whereas the respective trans-isomer was inactive. Although cis- (6) and transanol (7) were both less active against Gram-negative than Gram-positive bacteria, they differed markedly in their activity against C. albicans. A pronounced overall activity was observed with E-1-propenylphenol (4) and chavicol (5) , of which the latter turned out to be a strong inhibitor of P. aeruginosa ( Table 2 ).
The inhibitory data of dioxygenated VPs are arranged based on their oxygen substitution on the aromatic ring (Tables 3 to 5 ). The phenolic ortho-dioxygenated VPs exerted growth inhibitory and killing activities in a range of 300 to 1500 mg/L. Neither the 2,3-nor 3,4substitution patterns of the dioxygenated VPs had any significant influence on the antimicrobial activity. Exceptions were E-ortho-isoeugenol (21), for which no killing activity was observed at a maximum 3000 mg/L and P. aeruginosa, which was less sensitive to phenolic ortho-dioxygenated VPs. In contrast, the cis-isomer of ortho-isoeugenol (20) showed microbicidal activity. Interestingly, chavibetol (26) matched the closely related compound eugenol (23) in its growth inhibitory activity against Gram-negative bacteria. Like catechol (16) in this examination, hydroxychavicol (17) causes strong inhibition of all microorganisms, according to literature data [5, 6] . Etherification of phenolic ortho-dioxygenated VPs causes a reduction or loss of antimicrobial activity. Exceptions were methyleugenol (35), which killed S. aureus and an envelope defective strain of E. coli, but not normal strains, safrole (32), which had killing activity against K. pneumoniae, P. aeruginosa and S. aureus, and E-methylisoeugenol, which killed C. albicans. The compound without a propenyl side chain, 1,2-dimethoxybenzene (28), was inhibitory towards Gram-negative bacteria and S. aureus, which indicates that the propenyl side chain is not a functional group within the VPs that could be made responsible for the antimicrobial activity of the compound ( Table 3 ).
The phenolic meta-dioxygenated VPs all exerted growth inhibitory and killing activities in a range of 150 to 1750 mg/L. 2-Hydroxy-4-methoxy-allylbenzene (40) and 2-hydroxy-6-methoxy-allylbenzene (42) had higher activity than eugenol (23) against C. albicans, E. coli, and S. aureus. Again, P. aeruginosa and, in addition, K. pneumoniae were less susceptible against phenolic VPs. Etherification caused loss of activity of all compounds of this type tested ( Table 4 ).
The phenolic para-dioxygenated VPs all exerted growth inhibitory and killing activities in a range of <1 to 1000 Antimicrobial activity of phenylpropanes Natural Product Communications Vol. 5 (9) 2010 1391 Table 3 : Antimicrobial activity of ortho-dioxygenated phenylpropanes.
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Among the tetra-and pentaoxygenated VPs, 2-hydroxy-3,4,5-trimethoxy-allylbenzene (109) showed, in addition, considerable inhibitory activity against C. albicans. None of the other VPs caused any growth inhibition against the tested microorganisms. In comparison, Ψ-dillapiol (99) and Ψ-apiol (106) exhibited inhibitory properties against B. subtilis plus E. coli [8] , and agricultural pests [9] , according to literature data, respectively (Table 7 ).
In summary, the antimicrobial activity of VPs is influenced by: a) kind and number of substituents. Monohydroxylated VPs are usually active; compounds with 2 or more methoxyl-groups are less active against Gram-negative bacteria; etherified VPs are usually more active against Gram-positive bacteria and yeasts than against Gram-negative bacteria. Cis-isomers of the 1-propenyl side chain are partly more active than their respective transisomers. VP ethers were usually inactive against Gram-negative bacteria. Compounds of this type having 2 to 3 methoxyl-groups plus a 1-propenyl side chain exerted anticandidal activity. b) pattern of aromatic oxygenation, which is most pronounced for meta-substituted monohydroxymonomethoxy phenylpropanes. Ortho-and paradihydroxylated compounds are in part very active, whilst the respective meta-derivatives are inactive. Results for the etherified compounds do not allow such conclusions to be made. According to literature data, the selection of microbial strains, as well as the microbiologically [18] testing parameters influences the inhibitory data of eugenol (23) against E. coli [10] and P. aeruginosa ( Table 8 ).
The variation of results shown in Table 8 demonstrates the importance of measuring data in a uniform test system, whereas literature data cannot be compared with each other without consideration of the circumstances of data generation. The structure-activityrelationships observed in this study can, therefore, not be deduced from scattered data published in other works, which seems to be an underestimated problem in QSAR-studies and computational drug design.
